Nicolas Receveur

Principal Research Associate, Rare Blood Disorders
F. Hoffmann-La Roche, Ltd.

Presentation(s):

• PB0816 - In vitro investigation of emicizumab efficacy and mode of action in vWD type 2 and 3 samples

  Monday, July 11, 2022
  6:30 PM – 7:30 PM